Literature DB >> 16569692

FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts.

Kyoko Kakumoto1, Ken Sasai, Taiko Sukezane, Chitose Oneyama, Satoshi Ishimaru, Kana Shibutani, Hiroto Mizushima, Eisuke Mekada, Hidesaburo Hanafusa, Tsuyoshi Akagi.   

Abstract

Human diploid fibroblasts (HDF) immortalized by hTERT and simian virus 40 (SV40) early region (ER) exhibit a limited degree of transformation upon the expression of activated H-RAS (H-RAS V12) compared with rat embryonic fibroblasts (REF) immortalized by SV40 ER. Here, we identified FRA1 as a determinant for this difference in RAS-induced transformation. FRA1 was not induced by H-RAS V12 in the immortalized HDF, in contrast to its marked accumulation in the immortalized REF. Ectopic expression of FRA1 significantly enhanced anchorage-independent growth of various HDF expressing hTERT, SV40 ER, and H-RAS V12. More importantly, FRA1 could induce anchorage-independent growth as well as nude mice tumor formation of the immortalized HDF in the absence of H-RAS V12. The results of an in vitro kinase assay clearly showed that the RAS-induced extracellular signal-regulated kinase (ERK) activation, which is responsible for FRA1 induction, was markedly attenuated in the HDF compared with that in the REF, despite no obvious differences in the phosphorylation status of ERK between the species. Our results strongly suggest that HDF negatively regulate the mitogen-activated protein kinase kinase (MEK)/ERK pathway more efficiently than REF, and consequently express less malignant phenotypes in response to H-RAS V12.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16569692      PMCID: PMC1459382          DOI: 10.1073/pnas.0601222103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes.

Authors:  Nicole H Purcell; Dina Darwis; Orlando F Bueno; Judith M Müller; Roland Schüle; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

2.  An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry.

Authors:  Peter M Burch; Ziqiang Yuan; Anne Loonen; Nicholas H Heintz
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

3.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.

Authors:  Elizabeth Yeh; Melissa Cunningham; Hugh Arnold; Dawn Chasse; Teresa Monteith; Giovanni Ivaldi; William C Hahn; P Todd Stukenberg; Shirish Shenolikar; Takafumi Uchida; Christopher M Counter; Joseph R Nevins; Anthony R Means; Rosalie Sears
Journal:  Nat Cell Biol       Date:  2004-03-14       Impact factor: 28.824

4.  FRA-1 expression in hyperplastic and neoplastic thyroid diseases.

Authors:  G Chiappetta; G Tallini; M C De Biasio; F Pentimalli; F de Nigris; S Losito; M Fedele; S Battista; P Verde; M Santoro; A Fusco
Journal:  Clin Cancer Res       Date:  2000-11       Impact factor: 12.531

5.  Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation.

Authors:  Tsuyoshi Akagi; Ken Sasai; Hidesaburo Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

6.  Constitutive induction of p-Erk1/2 accompanied by reduced activities of protein phosphatases 1 and 2A and MKP3 due to reactive oxygen species during cellular senescence.

Authors:  Hong Seok Kim; Myeong-Cheol Song; In Hae Kwak; Tae Jun Park; In Kyoung Lim
Journal:  J Biol Chem       Date:  2003-07-02       Impact factor: 5.157

7.  Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization.

Authors:  Laura Casalino; Dario De Cesare; Pasquale Verde
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

8.  ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility.

Authors:  Emmanuel Vial; Erik Sahai; Christopher J Marshall
Journal:  Cancer Cell       Date:  2003-07       Impact factor: 31.743

9.  Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells.

Authors:  Emmanuel Vial; Christopher J Marshall
Journal:  J Cell Sci       Date:  2003-12-15       Impact factor: 5.285

10.  Extracellular signal-regulated kinases 1/2 are serum-stimulated "Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover.

Authors:  Rebecca Ley; Katherine E Ewings; Kathryn Hadfield; Elizabeth Howes; Kathryn Balmanno; Simon J Cook
Journal:  J Biol Chem       Date:  2003-12-17       Impact factor: 5.157

View more
  13 in total

1.  Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells.

Authors:  Wai Leong Tam; Haihui Lu; Joyce Buikhuisen; Boon Seng Soh; Elgene Lim; Ferenc Reinhardt; Zhenhua Jeremy Wu; Jordan A Krall; Brian Bierie; Wenjun Guo; Xi Chen; Xiaole Shirley Liu; Myles Brown; Bing Lim; Robert A Weinberg
Journal:  Cancer Cell       Date:  2013-09-09       Impact factor: 31.743

2.  All for one and FOSL1 for all: FOSL1 at the crossroads of lung and pancreatic cancer driven by mutant KRAS.

Authors:  Adrian Vallejo; Karmele Valencia; Silvestre Vicent
Journal:  Mol Cell Oncol       Date:  2017-04-05

3.  ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events.

Authors:  Sejeong Shin; Christopher A Dimitri; Sang-Oh Yoon; William Dowdle; John Blenis
Journal:  Mol Cell       Date:  2010-04-09       Impact factor: 17.970

4.  Different Roles of Negative and Positive Components of the Circadian Clock in Oncogene-induced Neoplastic Transformation.

Authors:  Chiharu Katamune; Satoru Koyanagi; Shoya Shiromizu; Naoya Matsunaga; Shigeki Shimba; Shigenobu Shibata; Shigehiro Ohdo
Journal:  J Biol Chem       Date:  2016-03-09       Impact factor: 5.157

5.  FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-κB axis.

Authors:  Zhengxin Chen; Shuai Wang; Hai-Lin Li; Hui Luo; Xiaoting Wu; Jiacheng Lu; Hong-Wei Wang; Yuanyuan Chen; Dan Chen; Wen-Ting Wu; Shuyu Zhang; Qiongqiong He; Daru Lu; Ning Liu; Yongping You; Wei Wu; Huibo Wang
Journal:  Mol Ther       Date:  2022-03-26       Impact factor: 12.910

Review 6.  FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer.

Authors:  A S Dhillon; E Tulchinsky
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

7.  O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies.

Authors:  Ken Sasai; Tsuyoshi Akagi; Eiko Aoyanagi; Kouichi Tabu; Sadao Kaneko; Shinya Tanaka
Journal:  Mol Cancer       Date:  2007-06-05       Impact factor: 27.401

8.  Fate and plasticity of the epidermis in response to congenital activation of BRAF.

Authors:  Suguna R Krishnaswami; Shantanu Kumar; Phillip Ordoukhanian; Benjamin D Yu
Journal:  J Invest Dermatol       Date:  2014-09-09       Impact factor: 8.551

9.  FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms.

Authors:  Xiaoling Zhang; Joseph Wu; Suju Luo; Terry Lechler; Jennifer Y Zhang
Journal:  Oncotarget       Date:  2016-06-07

10.  The Fra-1-miR-134-SDS22 feedback loop amplifies ERK/JNK signaling and reduces chemosensitivity in ovarian cancer cells.

Authors:  Jianmin Wu; Yimin Sun; Pei-Ying Zhang; Mengyao Qian; Hengchao Zhang; Xiao Chen; Di Ma; Yunsheng Xu; Xiaoming Chen; Kai-Fu Tang
Journal:  Cell Death Dis       Date:  2016-09-29       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.